Blood transfusion: What if ….?
Transfusion. 2024 Mar 19. doi: 10.1111/trf.17744. Online ahead of print.NO ABSTRACTPMID:38501252 | DOI:10.1111/trf.17744 (Source: Transfusion)
Source: Transfusion - March 19, 2024 Category: Hematology Authors: Emily Mayhew Source Type: research
Transfusing children with sickle cell disease using blood group genotyping when the pool of Black donors is limited
CONCLUSION: Although Rh-compatible donors were identified, blood units might not be available when needed and/or the extended phenotype or ABO group might not match the patient. A greater effort has to be made for the recruitment of Black donors to accommodate patients with SCD.PMID:38497419 | DOI:10.1111/trf.17778 (Source: Transfusion)
Source: Transfusion - March 18, 2024 Category: Hematology Authors: Gabriel Andr é Leiva-Torres Maude Cigna Jessica Constanzo-Yanez Maryse St-Louis Jos ée Perreault Jos ée Lavoie Genevi ève Laflamme Antoine Lewin Yves Pastore Nancy Robitaille Source Type: research
Evaluation of platelets componentized with the Reveos Automated Blood Processing System and stored for 7 days at room temperature in a non-Di(2-ethylhexyl) phthalate (DEHP) platelet pooling set
CONCLUSION: Reveos-processed PCs produced from overnight-hold WB performed better in hemostatic function assays and displayed reduced activation compared to fresh WB-derived PCs, although both PC groups maintained platelet quality throughout storage. Utilization of overnight WB for PC preparation with Reveos holds promise as an alternative method of producing platelets for transfusion purposes.PMID:38491915 | DOI:10.1111/trf.17780 (Source: Transfusion)
Source: Transfusion - March 16, 2024 Category: Hematology Authors: Kristin M Reddoch-Cardenas Samantha L Perez Justin N Ferdin Michael A Meledeo Source Type: research
Ethical considerations in the use of RhD-positive blood products in trauma
Transfusion. 2024 Mar 16. doi: 10.1111/trf.17787. Online ahead of print.ABSTRACTBACKGROUND: Prehospital and early in-hospital use of low titer group O whole blood (LTOWB) for life-threatening bleeding has been independently associated with improved survival compared to component therapy. However, when RhD-positive blood products are administered to RhD-negative females of childbearing potential (FCP), there is a small future risk of hemolytic disease of the fetus and newborn (HDFN). This raises important ethical questions that must be explored in order to justify the use of RhD-positive blood products, including LTOWB, bot...
Source: Transfusion - March 16, 2024 Category: Hematology Authors: Jay R Malone Source Type: research
A case of transfusion-transmission Anaplasma phagocytophilum from leukoreduced red blood cells
CONCLUSION: This is a confirmed case of TT-HGA. Although rare, TT-HGA has been reported with LR-RBCs and platelets. In endemic areas, testing for tick-borne associated infections should be considered when investigating post-transfusion complications.PMID:38491925 | DOI:10.1111/trf.17783 (Source: Transfusion)
Source: Transfusion - March 16, 2024 Category: Hematology Authors: Laura Tonnetti Luis A Marcos Linda Mamone Eric D Spitzer Matthew Jacob Rebecca L Townsend Susan L Stramer Fay B West Source Type: research
Evaluation of platelets componentized with the Reveos Automated Blood Processing System and stored for 7 days at room temperature in a non-Di(2-ethylhexyl) phthalate (DEHP) platelet pooling set
CONCLUSION: Reveos-processed PCs produced from overnight-hold WB performed better in hemostatic function assays and displayed reduced activation compared to fresh WB-derived PCs, although both PC groups maintained platelet quality throughout storage. Utilization of overnight WB for PC preparation with Reveos holds promise as an alternative method of producing platelets for transfusion purposes.PMID:38491915 | DOI:10.1111/trf.17780 (Source: Transfusion)
Source: Transfusion - March 16, 2024 Category: Hematology Authors: Kristin M Reddoch-Cardenas Samantha L Perez Justin N Ferdin Michael A Meledeo Source Type: research
Ethical considerations in the use of RhD-positive blood products in trauma
Transfusion. 2024 Mar 16. doi: 10.1111/trf.17787. Online ahead of print.ABSTRACTBACKGROUND: Prehospital and early in-hospital use of low titer group O whole blood (LTOWB) for life-threatening bleeding has been independently associated with improved survival compared to component therapy. However, when RhD-positive blood products are administered to RhD-negative females of childbearing potential (FCP), there is a small future risk of hemolytic disease of the fetus and newborn (HDFN). This raises important ethical questions that must be explored in order to justify the use of RhD-positive blood products, including LTOWB, bot...
Source: Transfusion - March 16, 2024 Category: Hematology Authors: Jay R Malone Source Type: research
A case of transfusion-transmission Anaplasma phagocytophilum from leukoreduced red blood cells
CONCLUSION: This is a confirmed case of TT-HGA. Although rare, TT-HGA has been reported with LR-RBCs and platelets. In endemic areas, testing for tick-borne associated infections should be considered when investigating post-transfusion complications.PMID:38491925 | DOI:10.1111/trf.17783 (Source: Transfusion)
Source: Transfusion - March 16, 2024 Category: Hematology Authors: Laura Tonnetti Luis A Marcos Linda Mamone Eric D Spitzer Matthew Jacob Rebecca L Townsend Susan L Stramer Fay B West Source Type: research
A monthly roundup of key articles in other journals
Transfusion. 2024 Mar 15. doi: 10.1111/trf.17781. Online ahead of print.NO ABSTRACTPMID:38487985 | DOI:10.1111/trf.17781 (Source: Transfusion)
Source: Transfusion - March 15, 2024 Category: Hematology Authors: Caitlin McOmish Source Type: research
In response: Caution in prediction: Evaluating Zhang et al.'s approach to red blood cell transfusion risk
Transfusion. 2024 Mar;64(3):560-561. doi: 10.1111/trf.17731.NO ABSTRACTPMID:38488273 | DOI:10.1111/trf.17731 (Source: Transfusion)
Source: Transfusion - March 15, 2024 Category: Hematology Authors: Sarah J Power Kenneth E Stewart Kenichi A Tanaka Amir L Butt Source Type: research
Reply
Transfusion. 2024 Mar;64(3):564-565. doi: 10.1111/trf.17736.NO ABSTRACTPMID:38488278 | DOI:10.1111/trf.17736 (Source: Transfusion)
Source: Transfusion - March 15, 2024 Category: Hematology Authors: Evan G Pivalizza Maggie M Swift Jeffrey H Fair Source Type: research
Continuing Medical Education
Transfusion. 2024 Mar;64(3):466. doi: 10.1111/trf.17751.NO ABSTRACTPMID:38488285 | DOI:10.1111/trf.17751 (Source: Transfusion)
Source: Transfusion - March 15, 2024 Category: Hematology Source Type: research
In response: Caution in extrapolating hypercoagulable viscoelastic coagulation test results to in vivo hemostasis
Transfusion. 2024 Mar;64(3):563-564. doi: 10.1111/trf.17734.NO ABSTRACTPMID:38488286 | DOI:10.1111/trf.17734 (Source: Transfusion)
Source: Transfusion - March 15, 2024 Category: Hematology Authors: Amir L Butt Srikiran Ramarapu Hiroki Kyo Kenichi A Tanaka Source Type: research
Reply
Transfusion. 2024 Mar;64(3):561-563. doi: 10.1111/trf.17733.NO ABSTRACTPMID:38488297 | DOI:10.1111/trf.17733 (Source: Transfusion)
Source: Transfusion - March 15, 2024 Category: Hematology Authors: Qiaoni Zhang Yuchen Gao Tianlong Wang Zhiyuan Bo Bingyang Ji Source Type: research
Managing blood product shortages: Unprecedented challenges require novel solutions
Transfusion. 2024 Mar;64(3):565-566. doi: 10.1111/trf.17723.NO ABSTRACTPMID:38488299 | DOI:10.1111/trf.17723 (Source: Transfusion)
Source: Transfusion - March 15, 2024 Category: Hematology Authors: Jeremy W Jacobs Sheharyar Raza Jennifer S Woo Source Type: research
